« Return to News | Study Conduct | Technology Solutions

Acurian Uses Facebook to Promote Clinical Trial Participation

Wednesday, January 21, 2009 09:17 AM

Patient recruitment provider Acurian hopes the popularity of MySpace and Facebook will transfer to the clinical trial industry with its new social networking application, Click it Forward.

The new free application, which users can add to their existing Facebook and MySpace pages, is designed to promote clinical research and volunteering in clinical trials, as well as help grow Acurian’s existing database of individuals who have opted to receive information on clinical trial opportunities.

“Social networking is an ideal environment for promoting clinical trial awareness and increasing Acurian’s direct-to-patient recruitment capabilities,” said Acurian’s vice president of marketing Scott Connor in a company release. “Facebook and MySpace together have nearly 200 million registered users, and we believe that Click it Forward plays well to these online audiences based on the application’s healthcare and altruistic characteristics.”

Users can also gain points to raise money for more than 20 medical causes by inviting online friends to install the Click it Forward application to their own Facebook and MySpace pages,. The more points a user amasses, the more money Acurian will donate to the user’s preferred medical causes (selected upon registration).

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.